Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

14.81 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

24 25 Next >

IOVANCE INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Long-Term Iovance, Inc. Stockholders

October 29, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Iovance Biotherapeutics to Host Third Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, November 6, 2025

October 23, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Adaptimmune Plunges After Announcing Nasdaq Delisting Amidst Compliance Failures and Cost-Cutting Measures

October 20, 2025

Adaptimmune Therapeutics plc (NASDAQ: ADAP) has sent shockwaves through the biotechnology sector with its announcement on October 20, 2025, of a voluntary delisting of its American Depositary Shares...

Via MarketMinute

Iovance Stock Rises 4% On Health Canada Approval For Cancer Immunotherapy: Retail Thinks ‘Patience Will Pay Off’ ↗

August 19, 2025

Via Stocktwits

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

October 17, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Turnstone Biologics: A $100 Dream Collides with a $0.34 Reality

October 17, 2025

October 17, 2025 – In the volatile world of biotechnology, ambitious price targets often fuel investor speculation and market buzz. However, for Turnstone Biologics Corp. (NASDAQ: TSTN), the notion of...

Via MarketMinute

Topics Intellectual Property Workforce

Better Beaten-Down Stock: Iovance Biotherapeutics vs. Teladoc Health ↗

October 17, 2025

Is there a glimmer of hope for either of these underperforming healthcare companies?

Via The Motley Fool

Is Iovance Biotherapeutics Stock Your Ticket to Becoming a Millionaire? ↗

October 13, 2025

Investors have certainly seen explosive gains from shares of biopharma companies in similar situations.

Via The Motley Fool

IOVANCE (IOVA) ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Iovance Biotherapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

October 08, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

September 19, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Can This Beaten-Down Stock Bounce Back? ↗

September 19, 2025

This biotech company is innovative, but the market demands more than that.

Via The Motley Fool

Advancing Cancer Research Brings New Hope for Patients Worldwide

September 17, 2025

Via Investor Brand Network

Topics Artificial Intelligence Intellectual Property

Advancing Cancer Research Brings New Hope for Patients Worldwide

September 17, 2025

EQNX::TICKER_START (OTCQB:OTLC),(NASDAQ:IOVA),(NYSE:MRK),(NASDAQ:AZN),(NYSE:BMY) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Artificial Intelligence Intellectual Property

Iovance Biotherapeutics to Present at Upcoming Conferences

August 29, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

If You'd Invested $1,000 in IOVA 3 Years Ago, Here's How Much You'd Have Today ↗

August 27, 2025

The company hasn't been popular among investors since winning its first FDA approval more than a year ago.

Via The Motley Fool

Why Iovance Biotherapeutics Stock Got Mashed on Monday ↗

August 25, 2025

The company announced a flotation of its common shares that is potentially quite dilutive.

Via The Motley Fool

Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday ↗

August 25, 2025

Via Benzinga

1 Beaten-Down Stock That Could Soar By 261%, According to Wall Street ↗

August 24, 2025

Time is running out for the company to mount a comeback.

Via The Motley Fool

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

August 22, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Why Iovance Biotherapeutics Stock Was Climbing Today ↗

August 19, 2025

One and a half years after getting the nod from the U.S. Food and Drug Administration, its Amtagvi moves forward in a neighboring country.

Via The Motley Fool

Intel, Plymouth Industrial REIT, Premier And Other Big Stocks Moving Higher On Tuesday ↗

August 19, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 19, 2025

Via Benzinga

Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket ↗

August 19, 2025

Via Benzinga

Curious about the stocks that are showing activity after the closing bell on Monday? ↗

August 18, 2025

As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

Iovance’s Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma

August 18, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

3 Stocks That Could Turn $1,000 Into $5,000 by 2030 ↗

August 09, 2025

All three of these companies are entering a period of what could produce unparalleled top- and bottom-line growth.

Via The Motley Fool

Why Iovance Biotherapeutics Stock Plummeted Today ↗

August 08, 2025

The company's top line nearly doubled.

Via The Motley Fool

What 7 Analyst Ratings Have To Say About Iovance Biotherapeutics ↗

August 08, 2025

Via Benzinga

Pinterest Posts Downbeat Q2 Earnings, Joins Twilio, Trade Desk And Other Big Stocks Moving Lower In Friday Pre-Market Session ↗

August 08, 2025

Via Benzinga

Which stocks are moving before the opening bell on Friday? ↗

August 08, 2025

Before the opening bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

24 25 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.